首页> 外文OA文献 >Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies

【2h】

Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies

机译：异基因造血干细胞移植患者血液中的扭转性Teno病毒

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Masouridi Levrat, Stavroula; Pradier, Amandine; Simonetta, Federico; Kaiser, Laurent; Chalandon, Yves; Roosnek, Eddy Emile;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies [J] . Masouridi-Levrat S., Pradier A., Simonetta F., Bone marrow transplantation . 2016,第3期

机译：异基因造血干细胞移植患者血液中的扭转性Teno病毒
2. Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J] . Monzr M. Al Malki, Nitya Nathwani, Dongyun Yang, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第9期

机译：基于Melphalan的减少强度调节与70岁的患者有良好的疾病控制和可接受的毒性有关，血液学恶性肿瘤患者经历了同种异体造血干细胞移植
3. Impact of ATG Dose on the Outcome of Patients Undergoing Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies [J] . Cornillon Jerome, Balsat Marie, Cabrespine Aurelie, Acta Haematologica . 2016,第4期

机译：ATG剂量对降低强度条件后继发异基因造血干细胞移植治疗血液系统恶性肿瘤患者结果的影响
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Melphalan-based reduced intensity conditioning is associated with favorable disease control and acceptable toxicities in patients older than 70 with hematologic malignancies undergoing allogeneic hematopoietic stem cell transplantation [O] . Monzr M. Al Malki, Nitya Nathwani, Dongyun Yang, -1

机译：基于Melphalan的降低强度调节与70岁以上接受异基因造血干细胞移植的血液系统恶性肿瘤的患者良好的疾病控制和可接受的毒性相关
7. Outcomes of Patients Older Than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies [O] . Brunner Andrew M., Chen Yi-Bin, Kim Haesook, 2013

机译：超过70岁的患者接受异基因造血干细胞移植治疗血液系统恶性肿瘤的结果

Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies

著录项

引文网络

相似文献

相关主题

期刊订阅